SRTS
Sensus Healthcare Inc.
$3.39
+$0.09(+2.73%)
70
Overall
60
Value
81
Tech
--
Quality
Market Cap
$54.09M
Volume
113.10K
52W Range
$3.03 - $9.33
Target Price
$8.50
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||
| Total Revenue | $14.8M | $20.6M | $26.4M | $27.3M | $9.6M | $27.0M | $44.5M | $24.4M | $41.8M | ||
| Total Revenue | $14.8M | $20.6M | $26.4M | $27.3M | $9.6M | $27.0M | $44.5M | $24.4M | $41.8M | ||
| COST OF GOODS SOLD | |||||||||||
| Cost of Revenue | $-5.0M | $-6.8M | $-9.5M | $-9.7M | $4.3M | $10.1M | $14.9M | $10.3M | $17.4M | ||
| GROSS PROFIT | |||||||||||
| Gross Profit | $9.8M | $13.8M | $16.9M | $17.6M | $5.2M | $17.0M | $29.6M | $14.1M | $24.4M | ||
| OPERATING EXPENSES | |||||||||||
| Operating Expenses | $-10.2M | $-17.5M | $-18.9M | $-19.5M | $13.5M | $12.9M | $14.8M | $14.4M | $16.3M | ||
| Research & Development | $1.8M | $5.5M | $6.3M | $6.4M | $4.2M | $3.4M | $3.5M | $3.7M | $4.2M | ||
| Research Expense | $1.8M | $5.5M | $6.3M | $6.4M | $4.2M | $3.4M | $3.5M | $3.7M | $4.2M | ||
| Selling, General & Administrative | $8.4M | $12.0M | $12.7M | $13.1M | $9.3M | $9.4M | $11.3M | $10.8M | $12.1M | ||
| Selling & Marketing Expenses | $4.9M | $8.3M | $8.5M | $9.1M | $5.3M | $4.8M | $6.3M | $5.6M | $5.0M | ||
| General & Administrative Expenses | $3.5M | $3.7M | $4.1M | $4.0M | $4.0M | $4.6M | $5.0M | $5.2M | $7.1M | ||
| Promotion & Advertising | $-1.1M | $-1.7M | $-1.5M | $-1.3M | $515.0K | $460.0K | $900.0K | -- | -- | ||
| Salaries & Wages | $-726.4K | $-405.9K | -- | -- | $386.0K | $415.0K | -- | -- | -- | ||
| Depreciation & Amortization | $-241.0K | $-291.0K | $-562.0K | $-449.0K | $613.0K | $509.0K | $219.0K | $200.0K | $200.0K | ||
| Depreciation & Amortization | $-241.0K | $-291.0K | $-562.0K | $-449.0K | $613.0K | $509.0K | $219.0K | -- | -- | ||
| Amortization | $-96.0K | $-96.0K | $-96.0K | $-96.0K | $108.0K | $208.0K | $194.0K | $186.0K | $193.0K | ||
| Other Operating Expenses | -- | $-191.4K | $13.3K | $-351.0K | $373.0K | $335.0K | $255.0K | -- | -- | ||
| OPERATING INCOME | |||||||||||
| Operating income | $-363.1K | $-3.7M | $-2.0M | $-2.0M | $-8.2M | $4.1M | $14.8M | $-382.0K | $8.1M | ||
| EBITDA | $13.0K | $-3.3M | $-1.2M | $-1.2M | $-6.1M | $4.8M | $15.3M | $79.0K | $8.5M | ||
| NON-OPERATING ITEMS | |||||||||||
| Interest Expense (Non-Operating) | $21.9K | $68.9K | $156.7K | -- | $14.0K | $2.0K | $2.0K | $-992.0K | $-932.0K | ||
| Intinc | -- | -- | -- | -- | -- | $2.0K | $382.0K | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-21.9K | $-68.9K | $-156.7K | -- | $-14.0K | $-2.0K | $380.0K | $992.0K | $932.0K | ||
| Gain on Sale of Securities | $38.5K | $75.8K | $139.3K | $268.3K | $66.0K | $2.0K | -- | -- | -- | ||
| Other Income/Expense | $-38.5K | $-75.8K | $-139.3K | $-268.3K | $-1.4M | $1.0K | $12.8M | $-42.0K | $-347.0K | ||
| Other Special Charges | -- | -- | -- | -- | $1.3M | -- | -- | -- | -- | ||
| SPECIAL ITEMS | |||||||||||
| Special Income Charges | -- | -- | -- | -- | -- | $-88.0K | -- | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $88.0K | -- | -- | -- | ||
| PRE-TAX INCOME | |||||||||||
| EBIT | $-324.6K | $-3.6M | $-1.9M | $-1.7M | $-6.8M | $4.2M | $14.8M | $-382.0K | $8.1M | ||
| Pre-Tax Income | $-346.4K | $-3.7M | $-2.0M | $-1.7M | $-6.8M | $4.1M | $28.0M | $652.0K | $9.0M | ||
| INCOME TAX | |||||||||||
| Tax Provision | -- | $-562.0K | $-562.0K | -- | $1.3M | $-1.1M | $3.7M | $167.0K | $2.4M | ||
| NET INCOME | |||||||||||
| Net Income | $-346.4K | $-3.7M | $-2.0M | $-1.7M | $-6.8M | $4.1M | $24.2M | $485.0K | $6.6M | ||
| Net Income (Continuing Operations) | $-346.4K | $-3.7M | $-2.0M | $-1.7M | $-6.8M | $4.1M | $24.2M | $485.0K | $6.6M | ||
| Net Income (Discontinued Operations) | $-346.4K | $-3.7M | $-2.0M | $-1.7M | $-6.8M | $4.1M | $24.2M | $485.0K | $6.6M | ||
| Net Income (Common Stockholders) | $-346.4K | $-3.7M | $-2.0M | $-1.7M | $-6.8M | $4.1M | $24.2M | $485.0K | $6.6M | ||
| TOTALS | |||||||||||
| Total Expenses | $-15.2M | $-24.3M | $-28.4M | $-29.2M | $17.8M | $22.9M | $29.7M | $24.8M | $33.7M | ||
| SHARE & EPS DATA | |||||||||||
| Average Shares Outstanding | $12.0M | $13.2M | $14.1M | $16.2M | $16.4M | $16.5M | $16.5M | $16.3M | $16.3M | ||
| Average Shares Outstanding (Diluted) | $11.5M | $13.3M | $14.4M | $17.0M | $16.4M | $16.5M | $16.6M | $16.3M | $16.4M | ||
| Shares Outstanding | $13.5M | $13.5M | $16.4M | $16.5M | $16.5M | $16.7M | $16.4M | $16.4M | $16.4M | ||
| Basic EPS | -- | -- | -- | -- | $-0.42 | $0.25 | $1.47 | $0.03 | $0.41 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-0.42 | $0.25 | $1.47 | $0.03 | $0.41 | ||
| Diluted EPS | $-0.03 | $-0.28 | $-0.14 | $-0.10 | $-0.42 | $0.25 | $1.46 | $0.03 | $0.41 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $0.25 | $1.46 | $0.03 | $0.41 | ||
| OTHER METRICS | |||||||||||
| Accrued Preferred Stock Dividends | $-2.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | $-1.0K | $12.8M | $42.0K | -- | ||
| Interest Expense Operating | -- | -- | -- | -- | -- | $104.0K | $96.0K | -- | -- | ||
| Other Gand A | $3.5M | $3.7M | $4.1M | $4.0M | $4.0M | $4.6M | $5.0M | $5.2M | $7.1M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $-330.0K | $324.0K | $88.0K | -- | -- | -- | ||
| Other Write Off | -- | -- | -- | -- | -- | -- | $-107.0K | -- | -- | ||
| Otherunder Preferred Stock Dividend | $-2.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $-2.6M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $3.5M | $3.7M | $4.1M | $4.0M | -- | -- | -- | -- | -- | ||
| Selling Expense | $4.9M | $8.3M | $8.5M | $9.1M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SRTS | $3.39 | +2.7% | 113.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |